Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,755,883 papers from all fields of science
Search
Sign In
Create Free Account
ADAMTS13 gene
Known as:
DKFZp434C2322
, VON WILLEBRAND FACTOR-CLEAVING PROTEASE
, ADAM Metallopeptidase With Thrombospondin Type 1 Motif, 13 Gene
Expand
This gene plays a role in von Willebrand factor function.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
ADAMTS12 gene
ADAMTS13 Protein
ADAMTS13 protein, human
Blood coagulation
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.
Jian Zhu
,
J. Muia
,
+4 authors
J. Sadler
Blood
2019
Corpus ID: 59338220
Human ADAMTS13 is a multidomain protein with metalloprotease (M), disintegrin-like (D), thrombospondin-1 (T), Cys-rich (C), and…
Expand
2015
2015
miR-525-5p inhibits ADAMTS13 and is correlated with Ischemia/reperfusion injury-induced neuronal cell death.
Liyan Zhao
,
C. Hua
,
Yunqian Li
,
Qingqing Sun
,
Wei Wu
International Journal of Clinical and…
2015
Corpus ID: 30043665
The understanding of molecular mechanism underlying ischemia/reperfusion-induced neuronal death and neurological dysfunction may…
Expand
2014
2014
Carboxyl Terminus of ADAMTS13 Directly Inhibits Platelet Aggregation and Ultra Large von Willebrand Factor String Formation Under Flow in a Free-Thiol–Dependent Manner
J. Bao
,
Juan Xiao
,
Y. Mao
,
X. L. Zheng
Arteriosclerosis, Thrombosis and Vascular Biology
2014
Corpus ID: 37246985
Objective—ADAMTS13 (A Disintegrin And Metalloprotease with Thrombospondin type 1 repeats, 13) cleaves von Willebrand factor (VWF…
Expand
Review
2014
Review
2014
Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura
U. Budde
,
R. Schneppenheim
Hämostaseologie
2014
Corpus ID: 8243358
Summary The function of von Willebrand factor (VWF), a huge multimeric protein and a key factor in platelet dependent primary…
Expand
2013
2013
Simvastatin increases ADAMTS13 expression in podocytes.
Lei Shen
,
Guoyuan Lu
,
N. Dong
,
Zhen-ni Ma
,
C. Ruan
Thrombosis Research
2013
Corpus ID: 29103650
Review
2013
Review
2013
The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura.
L. Lotta
,
Haifeng M. Wu
,
K. Musallam
,
F. Peyvandi
Blood reviews
2013
Corpus ID: 6432925
2010
2010
Expression of terminal 2-6 – linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS 13 *
R. McGrath
,
T. Mckinnon
,
+6 authors
J. O’Donnell
2010
Corpus ID: 9019865
1Haemostasis Research Group, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Trinity…
Expand
2009
2009
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus
M. Skeppholm
,
A. Kallner
,
M. Kalani
,
G. Jörneskog
,
M. Blombäck
,
H. Wallén
Blood Coagulation and Fibrinolysis
2009
Corpus ID: 22924043
The von Willebrand factor (VWF) is elevated in patients with diabetes mellitus and degraded by a metalloprotease, ADAMTS13. We…
Expand
2007
2007
Plasma Levels of ADAMTS13 Antigen Determined with an Enzyme Immunoassay Using a Neutralizing Monoclonal Antibody Parallel ADAMTS13 Activity Levels
H. Yagi
,
S. Ito
,
Seiji Kato
,
H. Hiura
,
M. Matsumoto
,
Y. Fujimura
International journal of hematology
2007
Corpus ID: 25919881
Measurements of plasma ADAMTS13 activity (ADAMTS13: AC) have been used for the diagnosis of patients with thrombotic…
Expand
Review
2006
Review
2006
ADAMTS13 and microvascular thrombosis
H. Tsai
Expert Review of Cardiovascular Therapy
2006
Corpus ID: 22047189
Interaction between platelet and von Willebrand factor, a circulating adhesive glycoprotein, is essential for hemostasis under…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE